Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
European Journal of Nuclear Medicine and Molecular Imaging
Erschienen in:

11.08.2023 | Editorial

Strategy planning for turbulent times in nuclear medicine: Time to begin at the beginning?

verfasst von: Rayjanah Allie, Irfan Kayani, Gopinath Gnanasegaran, Sobhan Vinjamuri, Arturo Chiti, Diana Paez, Francesco Giammarile, Ken Herrmann, Jamshed Bomanji

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Strategy planning in nuclear medicine imaging in uncertain times can be a challenging task. In the traditional strategic-planning model, managers attempt to forecast how the imaging landscape will evolve and how competitors will respond. They then define a multi-year plan to position their departments in this envisaged future state. That model worked well when the health landscape and economies were more stable, and the primary factors influencing future growth and expansion were easier to forecast. However, the world and the health landscape are changing so quickly that no service can plan for every eventuality. …
Literatur
1.
Prakash A, Jha SK, Mohanty R. Scenario planning for service quality: a Monte Carlo simulation study. J Strateg Manag. 2012;5(3):331–52.
2.
Li M, Garrison L Jr, Lee W, Kowal S, Wong W, Veenstra D. A pragmatic guide to assessing real option value for medical technologies. Value Health. 2022; 22:S1098–3015(22)02002–2.
3.
4.
5.
6.
Bohr A, Memarzadeh K. The rise of artificial intelligence in healthcare applications. Artif Intell Healthcare. 2020:25–60 In Principles of Gender-Specific Medicine Sex and Gender-Specific Biology in the Postgenomic Era, Elsevier Science 2023
7.
Bowman EH, Moskowitz GT. Real options analysis and strategic decision making. Organ Sci. 2001;12(6):772–7.CrossRef
8.
9.
Changing Mindsets to Realize the 2030. How to promote new mindsets and behaviours in public institutions to implement the Sustainable Development Goals. Agenda for Sustainable Development. United Nations Department of Economic and Social Affairs, New York. 2021. Accessed 2 Jul 2023.
10.
Huang HL, Gnanasegaran G, Paez D, Fanti S, Hacker M, Sathekge M, Bom HS, Cerci JJ, Chiti A, Lan X, Herrmann K, Scott AM, Vinjamuri S, Dorbala S, Estrada E, Pellet O, Orellana P, El-Haj N, Giammarile F, Abdel-Wahab M, Bomanji J. Correction to: nuclear medicine services after COVID-19: gearing up back to normality. Eur J Nucl Med Mol Imaging. 2020;47(9):2220 (Erratum for: Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2048-2053).CrossRefPubMedPubMedCentral
11.
Gnanasegaran G, Paez D, Sathekge M, Giammarile F, Fanti S, Chiti A, Bom H, Vinjamuri S, Pascual TN, Bomanji J. Coronavirus (COVID-19) pandemic mediated changing trends in nuclear medicine education and training: time to change and scintillate. Eur J Nucl Med Mol Imaging. 2022;49(2):427–35 (Erratum in: Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):234).CrossRefPubMed
12.
Graham R, Moreira AP, Glaudemans AWJM, Jensen LT, Mihaïlovic J, Nazarenko S, Ozcan Z, Piciu D, Wadsak W, Kunikowska J, Jamar F. 2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe. Eur J Nucl Med Mol Imaging. 2022;49(10):3309–15.CrossRefPubMedPubMedCentral
13.
Allam Z, Bibri SE, Sharpe SA. The rising impacts of the COVID-19 pandemic and the Russia-Ukraine war: energy transition, climate justice, global inequality, and supply chain disruption. Resources. 2022;11:99.CrossRef
14.
Brindis RG, Douglas PS, Hendel RC, American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Nuclear Cardiology, American Heart Association, et al. ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. J Am Coll Cardiol. 2005;46(8):1587–605.CrossRefPubMed
15.
16.
Kamel SI, Intenzo CM, Parker L, Rao V, Levin DC. Recent trends suggest possible inappropriate utilization of myocardial perfusion imaging. J Am Coll Radiol. 2019;16(8):1013–7.CrossRefPubMed
17.
Kumar R. Real options valuation. In: Valuation: theories and concepts. London: Academic Press. In Valuation, Theories and Concepts Academic Press Elsevier Inc 2016, p. 227–236.
18.
Glantz M, Mun J. Strategic real options analysis: managing risk through flexibility. In: Credit engineering for bankers. 2nd ed. Burlington: Academic Press. Elsevier Inc 2011, p. 295–308.
19.
Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Review Eur J Nucl Med. 1993;20:716–31.CrossRefPubMed
20.
Sartor O, de Bono J, Chi KN, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385(12):1091–103.CrossRefPubMedPubMedCentral
21.
Brownell GL. A history of positron imaging. Presented at the Celebration of the 50th Year of Services to the Massachusetts General Hospital, Cambridge, MA. 1999. https://​websites.​umich.​edu. Accessed 8 Jul 2023.
22.
Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369–79.PubMed
23.
24.
Metadaten
Titel
Strategy planning for turbulent times in nuclear medicine: Time to begin at the beginning?
verfasst von
Rayjanah Allie
Irfan Kayani
Gopinath Gnanasegaran
Sobhan Vinjamuri
Arturo Chiti
Diana Paez
Francesco Giammarile
Ken Herrmann
Jamshed Bomanji
Publikationsdatum
11.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2023
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-023-06379-x

Weitere Artikel der Ausgabe 1/2023

Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management

  • Open Access
  • Original Article

The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake

  • Short Communication

The value of bone SPECT/CT in evaluation of foot and ankle arthrodesis and adjacent joint secondary osteoarthritis

  • Original Article

The feasibility of quantitative assessment of dynamic 18F-fluorodeoxyglucose PET in Takayasu’s arteritis: a pilot study

  • Original Article

Improved diagnostic accuracy for coronary artery disease detection with quantitative 3D 82Rb PET myocardial perfusion imaging

  • Original Article

The diagnostic accuracy of radiolabeled PSMA-ligand PET for tumour staging in newly diagnosed prostate cancer patients compared to histopathology: a systematic review and meta-analysis

  • Review Article